Cargando…

Correction: Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy

Detalles Bibliográficos
Autores principales: Nimmo, Jacqui T., Verma, Ajay, Dodart, Jean-Cosme, Wang, Chang Yi, Savistchenko, Jimmy, Melki, Ronald, Carare, Roxana O., Nicoll, James A. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863168/
https://www.ncbi.nlm.nih.gov/pubmed/36681823
http://dx.doi.org/10.1186/s13195-022-01156-8
_version_ 1784875268644536320
author Nimmo, Jacqui T.
Verma, Ajay
Dodart, Jean-Cosme
Wang, Chang Yi
Savistchenko, Jimmy
Melki, Ronald
Carare, Roxana O.
Nicoll, James A. R.
author_facet Nimmo, Jacqui T.
Verma, Ajay
Dodart, Jean-Cosme
Wang, Chang Yi
Savistchenko, Jimmy
Melki, Ronald
Carare, Roxana O.
Nicoll, James A. R.
author_sort Nimmo, Jacqui T.
collection PubMed
description
format Online
Article
Text
id pubmed-9863168
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98631682023-01-22 Correction: Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy Nimmo, Jacqui T. Verma, Ajay Dodart, Jean-Cosme Wang, Chang Yi Savistchenko, Jimmy Melki, Ronald Carare, Roxana O. Nicoll, James A. R. Alzheimers Res Ther Correction BioMed Central 2023-01-21 /pmc/articles/PMC9863168/ /pubmed/36681823 http://dx.doi.org/10.1186/s13195-022-01156-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Nimmo, Jacqui T.
Verma, Ajay
Dodart, Jean-Cosme
Wang, Chang Yi
Savistchenko, Jimmy
Melki, Ronald
Carare, Roxana O.
Nicoll, James A. R.
Correction: Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
title Correction: Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
title_full Correction: Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
title_fullStr Correction: Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
title_full_unstemmed Correction: Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
title_short Correction: Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
title_sort correction: novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863168/
https://www.ncbi.nlm.nih.gov/pubmed/36681823
http://dx.doi.org/10.1186/s13195-022-01156-8
work_keys_str_mv AT nimmojacquit correctionnovelantibodiesdetectadditionalasynucleinpathologyinsynucleinopathiespotentialdevelopmentforimmunotherapy
AT vermaajay correctionnovelantibodiesdetectadditionalasynucleinpathologyinsynucleinopathiespotentialdevelopmentforimmunotherapy
AT dodartjeancosme correctionnovelantibodiesdetectadditionalasynucleinpathologyinsynucleinopathiespotentialdevelopmentforimmunotherapy
AT wangchangyi correctionnovelantibodiesdetectadditionalasynucleinpathologyinsynucleinopathiespotentialdevelopmentforimmunotherapy
AT savistchenkojimmy correctionnovelantibodiesdetectadditionalasynucleinpathologyinsynucleinopathiespotentialdevelopmentforimmunotherapy
AT melkironald correctionnovelantibodiesdetectadditionalasynucleinpathologyinsynucleinopathiespotentialdevelopmentforimmunotherapy
AT carareroxanao correctionnovelantibodiesdetectadditionalasynucleinpathologyinsynucleinopathiespotentialdevelopmentforimmunotherapy
AT nicolljamesar correctionnovelantibodiesdetectadditionalasynucleinpathologyinsynucleinopathiespotentialdevelopmentforimmunotherapy